These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 11476753

  • 1. The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors.
    Wicke K, Garcia-Ladona J.
    Eur J Pharmacol; 2001 Jul 20; 424(2):85-90. PubMed ID: 11476753
    [Abstract] [Full Text] [Related]

  • 2. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding.
    Malmberg, Mikaels, Mohell N.
    J Pharmacol Exp Ther; 1998 Apr 20; 285(1):119-26. PubMed ID: 9536001
    [Abstract] [Full Text] [Related]

  • 3. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC, Van Scharrenburg G, Ronken E, Hesselink MB, Reinders JH, Van Der Neut M, Long SK, Feenstra RW, McCreary AC.
    Synapse; 2006 Dec 15; 60(8):599-608. PubMed ID: 17001660
    [Abstract] [Full Text] [Related]

  • 4. Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation.
    Collo G, Zanetti S, Missale C, Spano P.
    Eur J Neurosci; 2008 Oct 15; 28(7):1231-40. PubMed ID: 18973551
    [Abstract] [Full Text] [Related]

  • 5. Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626.
    Bowery BJ, Razzaque Z, Emms F, Patel S, Freedman S, Bristow L, Kulagowski J, Seabrook GR.
    Br J Pharmacol; 1996 Dec 15; 119(7):1491-7. PubMed ID: 8968560
    [Abstract] [Full Text] [Related]

  • 6. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
    Sóvágó J, Makkai B, Gulyás B, Hall H.
    Eur J Neurosci; 2005 Jul 15; 22(1):65-71. PubMed ID: 16029196
    [Abstract] [Full Text] [Related]

  • 7. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C, Carilla-Durand E, Assié MB, Ormiere AM, Maraval M, Leduc N, Newman-Tancredi A.
    Eur J Pharmacol; 2006 Mar 27; 535(1-3):135-44. PubMed ID: 16554049
    [Abstract] [Full Text] [Related]

  • 8. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
    Heinrich JN, Brennan J, Lai MH, Sullivan K, Hornby G, Popiolek M, Jiang LX, Pausch MH, Stack G, Marquis KL, Andree TH.
    Eur J Pharmacol; 2006 Dec 15; 552(1-3):36-45. PubMed ID: 17056032
    [Abstract] [Full Text] [Related]

  • 9. Agonist-induced [35S]GTPgammaS binding in the membranes of Spodoptera frugiperda insect cells expressing the human D3 dopamine receptor.
    Pregenzer JF, Alberts GL, Im WB.
    Neurosci Lett; 1997 Apr 25; 226(2):91-4. PubMed ID: 9159497
    [Abstract] [Full Text] [Related]

  • 10. Excitation of type II anterior caudate neurons by stimulation of dopamine D3 receptors.
    Piercey MF, Hyslop DK, Hoffmann WE.
    Brain Res; 1997 Jul 11; 762(1-2):19-28. PubMed ID: 9262154
    [Abstract] [Full Text] [Related]

  • 11. Effects of the dopamine D3 antagonist PD 58491 and its interaction with the dopamine D3 agonist PD 128907 on brain dopamine synthesis in rat.
    Whetzel SZ, Shih YH, Georgic LM, Akunne HC, Pugsley TA.
    J Neurochem; 1997 Dec 11; 69(6):2363-8. PubMed ID: 9375667
    [Abstract] [Full Text] [Related]

  • 12. Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities.
    Kreiss DS, Bergstrom DA, Gonzalez AM, Huang KX, Sibley DR, Walters JR.
    Eur J Pharmacol; 1995 Apr 24; 277(2-3):209-14. PubMed ID: 7493610
    [Abstract] [Full Text] [Related]

  • 13. Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D3 receptor antagonist.
    Dubuffet T, Newman-Tancredi A, Cussac D, Audinot V, Loutz A, Millan MJ, Lavielle G.
    Bioorg Med Chem Lett; 1999 Jul 19; 9(14):2059-64. PubMed ID: 10450981
    [Abstract] [Full Text] [Related]

  • 14. Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor.
    Wood MD, Boyfield I, Nash DJ, Jewitt FR, Avenell KY, Riley GJ.
    Eur J Pharmacol; 2000 Oct 27; 407(1-2):47-51. PubMed ID: 11050289
    [Abstract] [Full Text] [Related]

  • 15. Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.
    Newman-Tancredi A, Cussac D, Brocco M, Rivet JM, Chaput C, Touzard M, Pasteau V, Millan MJ.
    Brain Res; 2001 Nov 30; 920(1-2):41-54. PubMed ID: 11716810
    [Abstract] [Full Text] [Related]

  • 16. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.
    Millan MJ, Cussac D, Gobert A, Lejeune F, Rivet JM, Mannoury La Cour C, Newman-Tancredi A, Peglion JL.
    J Pharmacol Exp Ther; 2004 Jun 30; 309(3):903-20. PubMed ID: 14978194
    [Abstract] [Full Text] [Related]

  • 17. Modulation of [(35)S]GTPgammaS binding to chinese hamster ovary cell membranes by D(2(short)) dopamine receptors.
    Terasmaa A, Finnman UB, Owman C, Ferré S, Fuxe K, Rinken A.
    Neurosci Lett; 2000 Feb 18; 280(2):135-8. PubMed ID: 10686396
    [Abstract] [Full Text] [Related]

  • 18. S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626.
    Millan MJ, Gobert A, Newman-Tancredi A, Lejeune F, Cussac D, Rivet JM, Audinot V, Dubuffet T, Lavielle G.
    J Pharmacol Exp Ther; 2000 Jun 18; 293(3):1048-62. PubMed ID: 10869410
    [Abstract] [Full Text] [Related]

  • 19. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul 18; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

  • 20. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
    Bowery B, Rothwell LA, Seabrook GR.
    Br J Pharmacol; 1994 Jul 18; 112(3):873-80. PubMed ID: 7921615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.